Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Clinical trial NCT01002755 · COMPLETED

Trial details

NCT number: NCT01002755
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia Fatigue Fever Hypogammaglobulinemia Lymphadenopathy Lymphocytosis Night Sweats Paraproteinemia Small Lymphocytic Lymphoma Thrombocytopenia

Start date: 2010-01-19
Primary completion: 2018-01-31
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.